Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-10 Registration of securities (Canada)
- 4.3 Indenture
- 5.1 Opinion of Sullivan & Cromwell LLP
- 5.2 Opinion of Borden Ladner Gervais LLP
- 5.3 Opinion of Stewart Mckelvey
- 5.4 Opinion of Lionel Sawyer & Collins
- 5.5 Opinion of Heller Ehrman White & Mcauliffe LLP
- 5.6 Opinion of Faegre & Benson LLP
- 5.7 Opinion of Mcconnell Valdes
- 5.8 Opinion of Herbert Smith LLP
- 23.1 Consent of Pricewaterhousecoopers LLP
- 23.2 Consent of Ernst & Young LLP
- 23.3 Consent of Hughes Pittman & Gupton LLP
- 25.1 Statement of Eligibility of the Trustee on Form T-1
- 99.1 Letter of Transmittal
- 99.2 Notice of Guaranteed Delivery
Angiotech Pharmaceuticals similar filings
Filing view
External links
EXHIBIT 23.3
[LETTERHEAD OF HUGHES PITTMAN & GUPTON, LLP]
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
Board of Directors
Angiotech Pharmaceuticals, Inc.
Vancouver, British Columbia
We hereby consent to the incorporation by reference into the combined Registration Statement on Forms F-10, F-4 and S-4 of Angiotech Pharmaceuticals, Inc., and the other subsidiary guarantor registrants listed therein, of our report on Quill Medical, Inc. dated February 21, 2006. We also consent to the reference to us under the heading “Independent Accountants” in such Registration Statement.
/s/ HUGHES PITTMAN & GUPTON, LLP
March 8, 2007
Raleigh, North Carolina